Multiple system atrophy, COQ2, ubiquinol, clinical trial, disease-modifying therapy
adhesion molecule, autoantibody, cerebellar ataxia, pyramidal tract sign, transmembrane protein family 132A (TMEM132A)
sporadic amyotrophic lateral sclerosis, AMPA receptor, perampanel, ALSFRS-R, ADAR2
bone marrow stromal cell, regenerative medicine, ischemic stroke, cell tracking, autologous cell therapy